COLORADO SPRINGS, Colo., Oct. 6 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that the company will release 2004 third-quarter financial results after market close on Tuesday, October 19, 2004. Company management will host an investment-community conference call beginning at 4:30 p.m. Eastern Time on Tuesday, October 19 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (888) 803-8271 for domestic callers, or (706) 634-2467 for international callers. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers and entering reservation code 1393939.
The live conference call will also be available via the Internet on the investor relations section of the company’s Web site at http://www.spectranetics.com/, and a recording of the call will be available on the investor relations section of the company’s Web site for 14 days following the completion of the call.
About Spectranetics
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system. Our CVX-300(R) excimer laser is the only system approved by the FDA for multiple cardiovascular procedures, including coronary atherectomy, and the removal of problematic pacemaker and defibrillator leads. Nearly all of our FDA-approved and investigational applications have received Communautes Europeennes (CE) mark registration for marketing within Europe. In April 2004, we obtained 510(k) clearance from the FDA for the laser-based treatment of patients suffering from total occlusions (blockages) in their leg arteries that are not crossable with a guide wire.
Spectranetics and CVX-300 are registered trademarks of The Spectranetics Corporation.
COMPANY CONTACT: Spectranetics Corporation John Schulte, Chief Executive Officer Guy Childs, Chief Financial Officer (719) 633-8333 http://www.spectranetics.com/ INVESTOR CONTACTS: Lippert/Heilshorn & Associates, Inc. Bruce Voss (bvoss@lhai.com) Ina McGuinness (imcguinness@lhai.com) (310) 691-7100 http://www.lhai.com/
Spectranetics Corporation
CONTACT: investors, Bruce Voss, bvoss@lhai.com, or Ina McGuinness,imcguinness@lhai.com, both of Lippert/Heilshorn & Associates, Inc.,+1-310-691-7100, for Spectranetics Corporation; or John Schulte, ChiefExecutive Officer, or Guy Childs, Chief Financial Officer, both ofSpectranetics Corporation, +1-719-633-8333
Web site: http://www.lhai.com/
Web site: http://www.spectranetics.com/